Clinical TrialsSearch results
Number of results: 253
Recruiting
- Prognostic study of risk stratification among Japanese patients with chronic kidney disease and ischemic heart disease using gated myocardial perfusion SPECT
- Chronic kidney disease, Ischemic heart disease
- Cardiovascular research foundation
- 2009-04-30
Recruiting
- Primary progressive multiple sclerosis (PPMS) Study of Bruton's tyrosine kinase (BTK) inhibitor SAR442168
- Primary Progressive Multiple Sclerosis
- Tanaka Tomoyuki
- 2020-11-18
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Prednisolone therapy of the first episode of idopatic nephrotic syndrome in children: A Multi-center randomized controlled trial
- Idiopatic nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2007-09-01
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Other
- PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
- Chronic Myeloid Leukemia (chronic phase)
- Inter-Michinoku Dasatinib Study(IMIDAS)
- 2009-04-23
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Recruiting
- Phase two clinical trial of limited stage lymphoblastic lymphoma.
- Limited stage lymphoblastic lymphoma
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Other
- Phase III study of VCAP-AMP-VECP vs. biweekly CHOP in aggressive adult T-cell leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.
- adult T-cell leukemia / lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-17